AzTrials
AzTrials

Recurrent Pregnancy LossNCT03905395

Meditation and Mindfulness for Recurrent Pregnancy Loss

A study testing Meditation and mindfulness in people with Recurrent Pregnancy Loss, run by Henriette Svarre Nielsen, MD, DMSc at 1 site in Denmark.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In the Danish Recurrent Pregnancy Loss Unit in Rigshospitalet in Copenhagen recurrent pregnancy loss (RPL) is defined as three og more consecutive pregnancy losses in accordance with current European guidelines. RPL affects approximately 3% of couples trying to achieve parenthood. Read more about this study

Who is it for?
Ages 18 to 46 years, women only
Conditions the study is for
Recurrent Pregnancy Loss
What is being tested?
Meditation and mindfulness
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteDenmark
Study dates
2 Feb 2019to 30 Jun 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 46 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Women with RPL
  • Speaking, reading and understanding Danish
  • Have given a written consent
  • Have a male partner
  • Have a stress score > 16 points on Perceived Stress Scale

Who cannot join

  • If the patient is pregnant on inclusion day
  • If the patient already is practing meditation and mindfulness
  • If the patient has a depression
  • If the patient develops a depression after inclusion in either arm

Trial locations and contacts

1 site in 1 country.

Henriette Svarre Nielsen, MD, DMSc contact

+4535458486

Henriette.Svarre.Nielsen@regionh.dk

Karen Henriette Kirchheiner Jensen, Nurse contact

+4535458486

Karen.Henriette.jensen@regionh.dk

Denmark1 site, 1 recruiting
  • Rigshospitalet

    Copenhagen, Østerbro, 2100

    Henriette Svarre Nielsen, MD. MDSc, +4535458486, Henriette.Svarre.Nielsen@regionh.dk

    Karen Kirchheiner Jensen, Nurse, +4535458486, Karen.Henriette.Jensen@regionh.dk

    Recruiting

Other trials in Denmark

About this study

In the Danish Recurrent Pregnancy Loss Unit in Rigshospitalet in Copenhagen recurrent pregnancy loss (RPL) is defined as three og more consecutive pregnancy losses in accordance with current European guidelines.

RPL affects approximately 3% of couples trying to achieve parenthood. Most cases of RPL are unexplained and have no effective treatment to improve the chance of a live birth.

Read more

42% of the women referred to RPL Unit in Rigshospitalet has a high stress level where as it's 22% in the background population trying to achieve parenthood. It's also known that 8,8 % of RPL patients have a depression at referral where as it's 2,2 % in the background population trying to achieve parenthood.

The study is a RCT including 62 patients - 31 in each arm. One arm will be taught in meditation and mindfulness three courses over a 7 week period. This group will also do meditation every day for 7 weeks. The other arm will have no intervention.

This study will investigate if a 7 weeks course in meditation and mindfulness is a useful tool to reduce stress and the psychological consequences for women and their partner treated in RPL Unit in Rigshospitalet, Copenhagen. Furthermore this study will investigate if there's a marital benefit such as reinforcement in their relationsship from practicing meditation and mindfulness.

There is no previous study that has investigated meditation and mindfulness for RPL.

This study has the potential to establish mental health support as a supplement to the medical and clinical treatment for RPL patients.

Read the detailed description

The loss of a desired pregnancy is a significant negative life event associated with grief comparable to the grief after a peri- or neonatal death. Recurrent pregnancy loss (RPL) defined as 3 or more pregnancy losses affects approximately 3% of couples trying to have children. Most cases of RPL are unexplained and have no effective treatment to improve the chance of a live birth.

42% of the women referred to RPL Unit in Rigshospitalet has a high stress level where as it's 22% in the background population trying to achieve parenthood. It's also known that 8,8% of RPL patients have a depression at referral where as it's 2,2 % in the background population trying to achieve parenthood.

This study will investigate if a 7 weeks course in meditation and mindfulness is a useful tool to reduce stress and the psychological consequences for women and their partner treated in RPL Unit in Rigshospitalet, Copenhagen.

Furthermore this study will investigate if there's a marital benefit from practicing meditation and mindfulness. The investigators will use four different scales to measure the participants stress, depression, marital benefit and fertility stress. Also the investigators will measure the participants before and after the intervention and 12 months after.

All participants will have to complete:

  1. Major Depression Index, a validated self-rating depression scale, which is used both clinically and in epidemiological studie. The 6-point Likert scale ranges from 0 (no depression) to 50 (extreme depression).
  2. Perceived Stress Scale, which is a validated 10-item-self-reporting scale for stress symptoms. The 5 point Likert scale ranges from 0 (no stress) to 40 (extreme stress).
  3. The COMPI Fertility Problem Stress Scale, a validated scale measuring the impact of RPL on the woman and her interpersonal relationships.
  4. The COMPI Marital Benefit Scale measuring if RPL has reinforced the couples mariage/relationship.

The investigators assume that meditation and mindfulness can improve the quality of life for the RPL patients and their coping strategies. It's the investigators purpose to contribute with new knowledge in this area for current and future patients.

The RPL Unit in Rigshospitalet doesn't have any psychological support apart from ordinary attention from the nurses. This study has the potential to establish mental health support as a supplement to the medical and clinical treatment for RPL patients, which is in high demand.

Being tested
Meditation and mindfulness
Keywords
Meditation, mindfulness, pregnancy loss, stress

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Meditation and mindfulnessBehavioural

    Women in the intervention arm will 3 times receive a three hours work shop with introduction to meditation and mindfulness over a 7 week period from a certified meditation instructor. Questionnaires before and after the intervention.

Study groups in NCT03905395
Study groupRoleWhat they receive
Meditation and mindfulness interventionActive comparatorWomen in the intervention arm will 3 times receive a three hours work shop with introduction to meditation and mindfulness over a 7 week period from a certified meditation instructor. Questionnaires before and after the intervention.
Receives: Behavioral: Meditation and mindfulness
Control groupNo interventionWomen in the no intervention arm will receive no introduction to meditation and mindfulness - only questionnaires at the same time as the intervention group receives questionnaires.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perceived Stress Scale (PSS)

    Change from baseline to 7 weeks after date of first course day measured by Perceived Stress Scale. PSS is a validated 10-item-self-reporting scale for stress symptoms. The 5 point Likert scale ranges from 0 (no stress) to 40 (extreme stress). The higher score the more stress.

    Measured: 7 weeks

  2. Perceived Stress Scale (PSS)

    Change from baseline to 12 months after date of first course day measured by the Perceived Stress Scale. PSS is a validated 10-item-self-reporting scale for stress symptoms. The 5 point Likert scale ranges from 0 (no stress) to 40 (extreme stress). The higher score the more stress.

    Measured: 12 months

Secondary outcomes (5)
  1. COMPI Fertility Problem Stress Scale

    Change from baseline to 7 weeks after date of first course day using the COMPI Fertility Problem Stress Scale.

    The COMPI Fertility Problem Stress Scale is a validated scale measuring the impact of RPL on the woman and her interpersonal relationships. Two questions asking if the experience of RPL has been stressful for the woman with five answering options. Followed by seven sub questions asking how big a load RPL has been for the patients interpersonal life with four answering options. The lower the score the higher stress.

    Measured: 7 weeks

  2. Marital Benefit Scale

    Change in marital benefit from baseline to 7 weeks after date of first course day using the COMPI Marital Benefit Scale.

    The COMPI Marital Benefit Scale has two questions asking what the RPL have mattered for their relationship/mariage:

    Five options to answer: totally disagree, partly disagree, neither agree or disagree, partly agree, totally agree. Answering "Totally agree" on both questions is defined as a high marital benefit.

    Measured: 7 weeks

  3. COMPI Fertility Problem Stress Scale

    Change in fertility problem stress from baseline to 12 months after date of first course day using the COMPI Fertility Problem Stress Scale.

    The COMPI Fertility Problem Stress Scale is a validated scale measuring the impact of RPL on the woman and her interpersonal relationships. Two questions used to assess how big a impact RPL has for the patient with five answering options. Followed by seven sub questions asking how big a load RPL has been for the patients interpersonal life with four answering options. The lower the score the higher stress.

    Measured: 12 months

  4. Marital Benefit

    Change in marital benefit from baseline to 12 months after date of first course day using the COMPI Marital Benefit Scale.

    The COMPI Marital Benefit Scale has two questions asking what the RPL have mattered for their relationship/mariage:

    Five options to answer: totally disagree, partly disagree, neither agree or disagree, partly agree, totally agree. Answering "Totally agree" on both questions is defined as a high marital benefit.

    Measured: 12 months

  5. Major Depression Index (MDI)

    Change in depression score from baseline to 12 months after date of first course day. Major Depression Index is a validated self-rating depression scale, which is used both clinically and in epidemiological studie. The 6-point Likert scale ranges from 0 (no depression) to 50 (extreme depression).

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2019
  2. Study start2 Feb 2019
  3. Primary completion30 Jun 2020 (estimated)
  4. Study completion30 Jun 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A randomized trial where women in an experimental arm will receive 3 times a three hour work shop with introduction to meditation and mindfulness during a 7 week period. Women in the other arm will have no intervention.
Masking
None (open label)
Enrolment
64 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03905395
Sponsor's protocol ID
H-18038456
Status last verified
Apr 2019
First submitted
2 Apr 2019
Last updated
5 Apr 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Meditation and mindfulness in people with Recurrent Pregnancy Loss, run by Henriette Svarre Nielsen, MD, DMSc at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Henriette Svarre Nielsen, MD, DMSc (+4535458486, Henriette.Svarre.Nielsen@regionh.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perceived Stress Scale (PSS) (time frame: 7 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in